Center for Research in Emerging Infectious Diseases-East and Central Africa (CREID-ECA)

Lead Organization: Washington State University
Pathogen Focus: MERS-CoV and Rift Valley Fever Virus

The CREID-ECA is located within the Washington State University (WSU) global health program in Nairobi, Kenya and overseen by an international team. The Center will use existing and new field sites established at human-animal-environment interfaces to conduct systematic pathogen discovery, and investigate the maintenance and transmission of Rift Valley fever virus (RVFV), and Middle East respiratory syndrome coronavirus (MERS-CoV). To support the response to recurrent outbreaks of infectious diseases (EIDs) in the regions, the Center will rapidly characterize novel pathogens and provide rapid diagnostics. The Center will build and cultivate links with national and regional outbreak response agencies with the goal of supporting timely epidemiologic and socio-cultural studies designed to identify and characterize causes, magnitude, scope and risk factors of infection; thereby strengthening responses to outbreaks and their optimal control. Our ultimate goal is to collect and translate data that provides needed evidence to minimize spread and burden of outbreak-associated pathogens. We will conduct the initial RVFV and MERS-CoV studies in five sites located in Kenya, Uganda, Tanzania, and the Democratic Republic of Congo (DRC).

This Research Center is supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number U01AI151799

M. Kariuki Njenga Principal Investigator Washington State University, Kenya Read Bio
Robert Breiman Co-Principal Investigator and Outbreak Response Lead Emory University Read Bio